# Articulinx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/articulinx

- Industry: Biotechnology
- Headquarters: Cupertino, US
- Website: www.articulinx.com
- Total disclosed funding: $21M
- Latest round: Series D (Dec 31, 2013)
- Investors on record: 2

## About

Articulinx is a technology company specializing in innovative solutions that enhance operational efficiency and customer engagement across various industries.Articulinx, founded in 2007 and headquartered in Cupertino, US, provides solutions aimed at addressing business challenges. The company has completed 4 deals, with its most recent deal in December 2013, raising USD 6.000 mn in Series D funding from US Venture Partners. The current company valuation stands at USD 30.048 mn.The company offers a range of core products and services tailored to meet the needs of diverse industries. Their primary offerings include innovative solutions designed to address challenges such as operational inefficiencies and customer engagement barriers. These products are utilized across sectors, providing users with enhanced functionality and streamlined processes. Articulinx serves a varied client base, including small to mid-sized enterprises and larger corporations, ensuring adaptability for different operational scales. Their market presence extends across North America, Europe, and parts of Asia, focusing on technology and service-oriented markets.Articulinx's revenue model incorporates multiple transaction types, including direct sales and subscription services. This structure allows clients to engage with the company's products through various pricing plans tailored to their specific needs. Flagship services may be offered on a subscription basis, providing ongoing access to software updates and customer support. Additionally, partnerships with wholesalers enhance broader distribution channels, ensuring efficient product reach. The revenue generation is supported by a combination of B2B transactions and direct customer engagements, fostering a sustainable financial ecosystem.The recent Series D funding raised in December 2013, amounting to USD 6.000 mn, is expected to support Articulinx in the development of new products and expansion into new markets. The company is focused on launching upcoming offerings designed to further enhance operational efficiencies. Plans are in place to expand into new geographic regions, particularly targeting markets in Asia and Europe by 2015, leveraging the recent funding to bolster these initiatives.

## Funding rounds

- Series D, Dec 31, 2013, $6M — US Venture Partners
- Series C, Dec 31, 2012, $5.1M — US Venture Partners
- Series B, Apr 13, 2010, $10M — US Venture Partners, De Novo Ventures

## Investors

- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series B, Series C, Series D
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series B